目的:探讨疏肝健脾方药对非酒精性脂肪性肝炎(NASH)大鼠肝细胞NF—κB信号通路相关基因及蛋白表达的影响。方法:将SD雄性大鼠随机分为8组:正常对照组、模型组、疏肝高/低剂量组、健脾高/低剂量组、合方高/低剂量组,每组15只。采用高脂饲料喂养复制大鼠NASH模型,16后检测肝脂、血脂,油红O和HE染色观察肝组织病理学变化。同时每组取6只采用离体循环灌注Ⅳ型胶原酶法分离肝细胞,RealtimeQ—PCR法Westernblot法分别检测各组大鼠肝细胞IKK、NF—κBmRNA和蛋白及磷酸化IKKβ蛋白表达。结果:与正常对照组比较,模型组大鼠肝细胞存在显著的脂质代谢紊乱;血清TC,肝脂及肝细胞IKKβ、NF—κBmRNA和蛋白表达及磷酸化IKK。蛋白表达较正常对照组均显著升高(P〈0.01);与模型组比较,健脾高剂量组、合方高剂量组大鼠肝细胞IKK、NF—xBmRNA表达水平显著降低(P〈0.05或P〈0.01),各药物干预组大鼠肝细胞IKK、NF—κB及磷酸化IKK。蛋白表达均显著下调(P〈0.05或P〈0.01),其中以健脾高剂量组、合方高剂量组下调趋势最为显著。结论:抑制肝细胞IKKJNF—κB信号通路相关基因及蛋白表达可能是疏肝健脾方药防治NASH的药理作用机制之-;上述蛋白可能是其药物作用的有效靶点。疏肝健脾方药对NASH的干预可能存在一定的量效关系。
Objective:To observe the effects of soothing liver and invigorating spleen recipes on NF-κB signal pathway related genes and proteins in primary hepatocytes of rats with NASH. Methods : SD male rats were randomly divided into 8 groups : normal, model,high/low-dose soothing liver group ,high/low-dose invigorating spleen group ,high/low-dose integrated group. 15 rats in each group. The NASH model rats were induced by feeding high-fat diet(HFD). The treatment lasted for 16 weeks. Then TC ,TG in the liver tissue and serum were determined with automatic biochemical analyzer. HE staining and oil red O staining were operated to observe the patho- logical changes. Another 6 rats of each group were taken respectively and collagenase (TypeIV)was perfused to digest liver tissue with the circulation in vitro to separate hepatocytes. The expression levels of IKKβ, NF-κB mRNA, proteins and phosphorylated IKKβ protein in hepatocytes of rats from each group were detected by Real-time Q-PCR and Western Blotting, respectively. Results:Compared with normal group,liver histopathology was changed and levels of TC and TG were elevated in model group indicating hepatocytes had lipid accumulation and lipid metabolic disturbance obviously;The levels of serum TC, and hepatic homogenate TC, TG as well as the expression of IKKβ, NF-κB mRNA, proteins and phosphorylated IKKβ protein in hepatocytes were dramatically increased in model group (P 〈 0. 01 ). Compared with the model group, the levels of IKKβ, NF-κB mRNA expression were decreased most significanly in the invigorating spleen (with high dose)group and the integrated group (with high dose ) (P 〈 0.01 or P 〈 0.05 ). The expression levels of the IKKβ, NF-κB proteins and the phosphorylated IKKβ protein in hepatocytes were decreased significaniy in the treatment groups (P 〈 0. 01 or P 〈 0.05 ), especially for the invigorating spleen ( with high dose) group and the integrated ( with high dose ). Conclusion : Soothing liver